Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe COVID 19 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06032000
What this trial is testing

Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)

Who this might be right for
COVID-19 InfectionCOVID-19 Vaccine Adverse Reaction
Lemonex 20
Not applicableNo Longer AvailableNCT04802083
What this trial is testing

COVID-19 Soliris Expanded Access Protocol

Who this might be right for
Covid19
Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)UnknownNCT05694962
What this trial is testing

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Jiangsu Cancer Institute & Hospital 40
Not applicableWithdrawnNCT04473183
What this trial is testing

Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota

Who this might be right for
Covid19SARS-CoV InfectionSARS-CoV-2+1 more
University of Minnesota
Large-scale testing (Phase 3)Study completedNCT04724629
What this trial is testing

Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)

Who this might be right for
Covid19
University of Sao Paulo 60
Not applicableStudy completedNCT06297122
What this trial is testing

Severe Group A Streptococcus Infections in Paris, France, 2018-2023

Who this might be right for
Invasive Group A Beta-Haemolytic Streptococcal Disease
Assistance Publique - Hôpitaux de Paris 269
Large-scale testing (Phase 3)Study completedNCT04613271
What this trial is testing

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia

Who this might be right for
Infectious DiseaseSARS-CoV InfectionCovid19
Ina-Respond 130
Large-scale testing (Phase 3)UnknownNCT04808895
What this trial is testing

Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19

Who this might be right for
COVID-19Thrombosis Pulmonary
Azienda Ospedaliera Universitaria Integrata Verona 204
Large-scale testing (Phase 3)Study completedNCT04447469
What this trial is testing

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Who this might be right for
COVID
Kiniksa Pharmaceuticals International, plc 814
Not applicableStudy completedNCT04570254
What this trial is testing

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19

Who this might be right for
Pneumonia, ViralCovid19ARDS+1 more
Unidad Temporal COVID-19 en Centro Citibanamex 110
Early research (Phase 1)Ended earlyNCT04659122
What this trial is testing

A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia

Who this might be right for
COVID-19Undefined
Airway Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT05077254
What this trial is testing

COVID Protection After Transplant-Immunosuppression Reduction

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT04392973
What this trial is testing

FAvipiravir and HydroxyChloroquine Combination Therapy

Who this might be right for
COVID19
King Abdullah International Medical Research Center 268
Large-scale testing (Phase 3)Study completedNCT07222384
What this trial is testing

Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 344
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Early research (Phase 1)WithdrawnNCT05630352
What this trial is testing

Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

Who this might be right for
COVID-19
BioNTech SE
Testing effectiveness (Phase 2)Study completedNCT04349098
What this trial is testing

Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc 190
Not applicableStudy completedNCT04506515
What this trial is testing

Psychological Impact of COVID-19 Pandemic in Healthcare Workers

Who this might be right for
Covid19Stress, PsychologicalWork Related Stress+2 more
Hospital General Universitario de Valencia 3,000
Not applicableUnknownNCT06006611
What this trial is testing

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

Who this might be right for
COVID-19
Fifth Affiliated Hospital, Sun Yat-Sen University 4,201
Not applicableUnknownNCT04637906
What this trial is testing

Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)

Who this might be right for
Covid19
University of Campania Luigi Vanvitelli 290
Next Page